Research prototype, not medical advice.

The TAME trial was designed to test whether metformin delays age-related diseases in humans.

Confidence
Speculative
Level of evidence
Observations in humans
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Deregulated nutrient sensingMetformin

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Metformin as a Tool to Target Aging
Barzilai et al. · Cell Metabolism 2016
— Verified